159 filings
Page 3 of 8
8-K
w18s g0tj4f
14 Nov 22
Exagen Inc. Reports Third Quarter 2022 Results
4:08pm
8-K
h8ks4k
20 Oct 22
Exagen Announces Appointment of John Aballi as CEO
4:05pm
424B5
y656hxouh3y
15 Sep 22
Prospectus supplement for primary offering
4:05pm
8-K
778f0t 6rgz86dka
15 Sep 22
Entry into a Material Definitive Agreement
4:03pm
8-K
tv7709q
4 Aug 22
Exagen Inc. Reports Second Quarter 2022 Results
4:06pm
8-K
bmz5l
21 Jun 22
Submission of Matters to a Vote of Security Holders
8:30am
S-8
7xm0s cozul6z8w4j
11 May 22
Registration of securities for employees
5:16pm
8-K
5lt30kvrv6fwi4xvn
11 May 22
Exagen Inc. Reports First Quarter 2022 Results
4:05pm
DEFA14A
g4tgpp5be2
28 Apr 22
Additional proxy soliciting materials
4:20pm
8-K
wruz0doj5chtmo1
28 Apr 22
Departure of Directors or Certain Officers
4:11pm
8-K
l9n6vdsf8 21e9au3xwk
22 Mar 22
Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results
4:05pm
8-K
4zteag nwvyf38mjtz7q
10 Jan 22
Regulation FD Disclosure
8:25am
8-K
4ipw94v
10 Nov 21
Exagen Inc. Reports Third Quarter 2021 Results
4:05pm
8-K
vifqjr7hsupb 1a0udus
25 Oct 21
Exagen Inc. Announces $27.2 Million Debt Refinancing
8:26am
8-K
hos6n92s9eoqg3vfnu
19 Oct 21
Entry into a Material Definitive Agreement
4:05pm